Cardiac MRI in Immune Checkpoint Inhibitor Associated Pericarditis

Abstract Checkpoint inhibitors are novel and promising anticancer agents. However, acute pericarditis is the second most common chemotherapy‐associated cardiotoxicity and associated with high mortality up to 21%. Cardiac MRI offers a one‐stop‐shop cardiac analysis to precisely detect chemotherapy‐as...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Can Öztürk, Julian A. Luetkens
Formato:	article
Lenguaje:	EN
Publicado:	Wiley 2021
Materias:	acute pericarditis cardiac magnetic resonance imaging immune checkpoint inhibitor PD‐1 inhibitor Medicine R Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/e54653fb25b14538966b182a2c2d5e80
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:e54653fb25b14538966b182a2c2d5e80
record_format	dspace
spelling	oai:doaj.org-article:e54653fb25b14538966b182a2c2d5e802021-12-02T07:55:56ZCardiac MRI in Immune Checkpoint Inhibitor Associated Pericarditis2050-090410.1002/ccr3.4926https://doaj.org/article/e54653fb25b14538966b182a2c2d5e802021-10-01T00:00:00Zhttps://doi.org/10.1002/ccr3.4926https://doaj.org/toc/2050-0904Abstract Checkpoint inhibitors are novel and promising anticancer agents. However, acute pericarditis is the second most common chemotherapy‐associated cardiotoxicity and associated with high mortality up to 21%. Cardiac MRI offers a one‐stop‐shop cardiac analysis to precisely detect chemotherapy‐associated cardiotoxicity without nephrotoxic contrast dye and ionizing radiation.Can ÖztürkJulian A. LuetkensWileyarticleacute pericarditiscardiac magnetic resonance imagingimmune checkpoint inhibitorPD‐1 inhibitorMedicineRMedicine (General)R5-920ENClinical Case Reports, Vol 9, Iss 10, Pp n/a-n/a (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	acute pericarditis cardiac magnetic resonance imaging immune checkpoint inhibitor PD‐1 inhibitor Medicine R Medicine (General) R5-920
spellingShingle	acute pericarditis cardiac magnetic resonance imaging immune checkpoint inhibitor PD‐1 inhibitor Medicine R Medicine (General) R5-920 Can Öztürk Julian A. Luetkens Cardiac MRI in Immune Checkpoint Inhibitor Associated Pericarditis
description	Abstract Checkpoint inhibitors are novel and promising anticancer agents. However, acute pericarditis is the second most common chemotherapy‐associated cardiotoxicity and associated with high mortality up to 21%. Cardiac MRI offers a one‐stop‐shop cardiac analysis to precisely detect chemotherapy‐associated cardiotoxicity without nephrotoxic contrast dye and ionizing radiation.
format	article
author	Can Öztürk Julian A. Luetkens
author_facet	Can Öztürk Julian A. Luetkens
author_sort	Can Öztürk
title	Cardiac MRI in Immune Checkpoint Inhibitor Associated Pericarditis
title_short	Cardiac MRI in Immune Checkpoint Inhibitor Associated Pericarditis
title_full	Cardiac MRI in Immune Checkpoint Inhibitor Associated Pericarditis
title_fullStr	Cardiac MRI in Immune Checkpoint Inhibitor Associated Pericarditis
title_full_unstemmed	Cardiac MRI in Immune Checkpoint Inhibitor Associated Pericarditis
title_sort	cardiac mri in immune checkpoint inhibitor associated pericarditis
publisher	Wiley
publishDate	2021
url	https://doaj.org/article/e54653fb25b14538966b182a2c2d5e80
work_keys_str_mv	AT canozturk cardiacmriinimmunecheckpointinhibitorassociatedpericarditis AT julianaluetkens cardiacmriinimmunecheckpointinhibitorassociatedpericarditis
_version_	1718399134024597504

Cardiac MRI in Immune Checkpoint Inhibitor Associated Pericarditis

Ejemplares similares